CDEK
← All drugs Report issue

montanide isa 720

Small moleculeexperimental

Clinical trial activity

20 trials · 31 clinical orgs · 0 marketing orgs

Phase 1
14
Phase 2
9
Phase 3
0
Phase 4
0

Earliest trial started May 1, 1999 (NCT00112216)

Timeline

1990s

  1. Jan 1, 1999

    Earliest Phase 1 Sponsor(trial)

2000s

  1. Jan 1, 2007

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • UnclearImmunity, active

    Unclear immunity, active

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • arlacel a
  • mannide monooleate
  • mannide mono-oleate
  • montanide
  • montanide
  • montanide isa 720
  • montanide isa 720
  • montanide isa 720

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02452775N/AMay 1, 2015University of Pennsylvania
NCT02240537Phase 1Jan 1, 2015Benovus Bio, Inc.
NCT01890980Phase 2Apr 1, 2013Cornell University, United States Army, University of Texas at Houston
NCT01250470Phase 1Sep 5, 2012National Cancer Institute (NCI), State University of New York, Buffalo
NCT01489956Early Phase 1 (Phase 1)Dec 1, 2011Icahn School of Medicine at Mount Sinai, Immune Tolerance Network, National Institute of Allergy and Infectious Diseases (NIAID)
NCT01312389Phase 1/Phase 2 (Phase 2)Mar 1, 2011University of Pennsylvania
NCT01265433Phase 2Dec 1, 2010Cornell University, Department of Defense
NCT01079741Phase 1/Phase 2 (Phase 2)Sep 1, 2010Cancer Research Institute, Icahn School of Medicine at Mount Sinai, Ludwig Institute for Cancer Research, New York University, Oncovir, Inc.
NCT00935545Phase 1Jul 1, 2009New York University
NCT00877448Phase 1/Phase 2 (Phase 2)Jun 1, 2009BiondVax Pharmaceuticals, Tel Aviv University
NCT00665002N/AJun 1, 2008Innovive Pharmaceuticals, University of South Florida
NCT00651703Phase 2Apr 1, 2008Cytos Biotechnology AG
NCT00509158Phase 1/Phase 2 (Phase 2)Oct 1, 2007Institut Pasteur, Radboud University
NCT00488592Phase 2Jun 1, 2007National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)
NCT00284973Phase 1Jan 1, 2006Jiao Tong University, PATH, People's Liberation Army of China, Shanghai Wanxing Bio-Pharmaceutical Co. Ltd., World Health Organization
NCT00124124Phase 1Jul 1, 2005Cancer Research Institute, Icahn School of Medicine at Mount Sinai, New York University
NCT01031524Phase 1/Phase 2 (Phase 2)Mar 1, 2004Radboud University, University of Basel, University of Lausanne
NCT00112242Phase 1Feb 1, 2004Ludwig Institute for Cancer Research, University of Lausanne
NCT00112229Phase 1Apr 1, 2003Ludwig Institute for Cancer Research, University of Lausanne
NCT00112216Phase 1May 1, 1999Ludwig Institute for Cancer Research, University of Lausanne
Showing 20 of 20 trials
Page 1 / 1

Organizations

Research & Development (31)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Ludwig Institute for Cancer ResearchAcademic/Hospital4021999
University of LausanneAcademic/Hospital4321999
Icahn School of Medicine at Mount SinaiAcademic/Hospital3222005
New York UniversityAcademic/Hospital3122005
Cancer Research InstituteAcademic/Hospital2022005
Cornell UniversityAcademic/Hospital2112010
Radboud UniversityAcademic/Hospital2112004
University of PennsylvaniaAcademic/Hospital2222011
Benovus Bio, Inc.For profit1112015
BiondVax PharmaceuticalsFor profit1112009
Cytos Biotechnology AGFor profit1112008
Department of DefenseGovernment1012010
Immune Tolerance NetworkAcademic/Hospital1012011
Innovive PharmaceuticalsFor profit1012008
Institut PasteurAcademic/Hospital1012007
Jiao Tong UniversityAcademic/Hospital1012006
National Cancer Institute (NCI)Government1012012
National Heart, Lung, and Blood Institute (NHLBI)Government1112007
National Institute of Allergy and Infectious Diseases (NIAID)Government1112011
National Institutes of Health (NIH)Government1012007
31 organizations
Page 1 / 2